跳至主要内容
临床试验/NCT00335517
NCT00335517已完成不适用

Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients

University of Rochester1 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2006年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
98
试验地点
1
主要终点
Number of Patients Enrolled and Recieving Injection

研究概览

简要总结

The purpose of the study is to help determine the appropriate dose of DepoDur for use in spinal surgery. The study will also assess the safety of this drug in this patient population.

详细描述

Patients will be recruited from the general practices of Drs. Rechtine, Rubery, Molinari, and Zeidman. An epidural catheter will be placed under direct vision at the conclusion of surgery. The catheter will be advanced at least 4 cm to L1 level prior to injection. Two milliliters of air will be injected through the catheter to ensure patency. Aspiration will then be done to ensure no intradural injections. Then the undiluted (1 or 1.5 cc) DepoDurTM will be injected.

The type of surgery will be recorded as to

  1. The number of levels of surgery.
  2. The number of levels fused
  3. The number of levels instrumented.
  4. The number of levels with an interbody fusion
  5. Time to ambulate
  6. Time to use oral analgesics
  7. The time of DepoDur injection.
  8. The amount of pain medications used in the 0-2 hour time interval after injection, 2-4 hours, and each subsequent 4 hour interval.
  9. Pain scores will be recorded with vital signs. (The pain score is from 1 to 10 and is asked orally to patients. This is part of the standard of care).

In a one-to-one randomization, patients will receive either a 10 or 15 mg dose of DepoDur at the time of surgery

Each patient will be provided with a morphine PCA (patient controlled analgesia) system postoperatively and then oral analgesics as appropriate. Analgesic requirements in morphine equivalents will be recorded. Comparison between the 10 and 15 mg dose will be done as to analgesic effectiveness and safety.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All mentally competent patients over the age of 18 undergoing lumbar surgery at L3-S1 who would be expected to be hospitalized for greater than 48 hours would be eligible for this study.

排除标准

  • Patients less than 18 years old, those not able to give consent, prisoners, patients with allergies to narcotic analgesics, and pregnant women will be excluded.
  • Women who are pregnant or are not practicing medically acceptable contraception (a pregnancy test is used pre-operatively as part of standard of care).
  • Patients who experience complications during the surgery (e.g., major hemorrhage, dural puncture) will not receive the study drug.

研究组 & 干预措施

10mg Depodur

Experimental

干预措施: DepoDur (Drug)

15mg DepoDur

Experimental

干预措施: DepoDur (Drug)

结局指标

主要结局

Number of Patients Enrolled and Recieving Injection

时间窗: 0-48 hours postoperatively

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Edward Puzas

Doctor

University of Rochester

研究点 (1)

Loading locations...

相似试验